# OnCo record aglatimagene-besadenovec (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/aglatimagene-besadenovec/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "aglatimagene-besadenovec" ;
  schema:name "Aglatimagene besadenovec"@en ;
  schema:alternateName "AdV-tk"@en ;
  schema:description "Aglatimagene besadenovec is an experimental gene therapy from Candel Therapeutics in phase 3 trials for non-small-cell lung cancer and prostate cancer, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/aglatimagene-besadenovec/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=CAN-2409>, <https://www.candeltx.com/pipeline/> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "gene therapy" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/prostate/> ;
  onco:companies <https://onco.cc/companies/candel-therapeutics/> ;
  onco:trials <https://onco.cc/trials/aurora/>, <https://onco.cc/trials/nct01436968/>, <https://onco.cc/trials/nct02768363/>, <https://onco.cc/trials/nct07332000/>, <https://onco.cc/trials/nct04495153/> .